Search research articles
Contact Us
Filters
Showing results (251-260 of 302) with videos related to
Page
of 31
Sort By:
Gynecologic Oncology
|
September 24, 2004
A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Teresa L Rutledge, Scott A Kamelle, Todd D Tillmanns, et al.
Surgical Oncology
|
September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations
David A Barrington, Ashley S Felix, Rieham Owda, et al.
Cells
|
April 27, 2026
Serum Extracellular Vesicle Protein Signatures Associated with Early-Stage High-Grade Serous Ovarian Carcinoma
Michelle Lightfoot, Kalpana Deepa Priya Dorayappan, Vignesh Vudatha, et al.
Gynecologic Oncology Reports
|
September 2, 2025
Exploratory evaluation of immunotherapy response and medication use in endometrial and cervical carcinoma
Julia Chalif, Molly Morton, Eric McLaughlin, et al.
Gynecologic Oncology
|
July 16, 2015
Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice
David E Cohn, Laura J Havrilesky, Kathryn Osann, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 10, 2012
Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases
Rowena C Mercado, Heather Hampel, Fay Kastrinos, et al.
Cancer Research
|
August 3, 2007
Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates
David Gius, Margo C Funk, Eric Y Chuang, et al.
Cancer Research
|
May 18, 2019
A Microfluidic Chip Enables Isolation of Exosomes and Establishment of Their Protein Profiles and Associated Signaling Pathways in Ovarian Cancer
Kalpana Deepa Priya Dorayappan, Miranda L Gardner, Colin L Hisey, et al.
Gynecologic Oncology
|
April 18, 2013
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
Israel Zighelboim, Jason D Wright, Feng Gao, et al.
American Journal of Obstetrics and Gynecology
|
August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer
Michelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 302) with videos related to
Sort By:
Page
of 31
Gynecologic Oncology
|
September 24, 2004
A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Teresa L Rutledge, Scott A Kamelle, Todd D Tillmanns, et al.
Surgical Oncology
|
September 6, 2020
Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations
David A Barrington, Ashley S Felix, Rieham Owda, et al.
Cells
|
April 27, 2026
Serum Extracellular Vesicle Protein Signatures Associated with Early-Stage High-Grade Serous Ovarian Carcinoma
Michelle Lightfoot, Kalpana Deepa Priya Dorayappan, Vignesh Vudatha, et al.
Gynecologic Oncology Reports
|
September 2, 2025
Exploratory evaluation of immunotherapy response and medication use in endometrial and cervical carcinoma
Julia Chalif, Molly Morton, Eric McLaughlin, et al.
Gynecologic Oncology
|
July 16, 2015
Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice
David E Cohn, Laura J Havrilesky, Kathryn Osann, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 10, 2012
Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases
Rowena C Mercado, Heather Hampel, Fay Kastrinos, et al.
Cancer Research
|
August 3, 2007
Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates
David Gius, Margo C Funk, Eric Y Chuang, et al.
Cancer Research
|
May 18, 2019
A Microfluidic Chip Enables Isolation of Exosomes and Establishment of Their Protein Profiles and Associated Signaling Pathways in Ovarian Cancer
Kalpana Deepa Priya Dorayappan, Miranda L Gardner, Colin L Hisey, et al.
Gynecologic Oncology
|
April 18, 2013
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
Israel Zighelboim, Jason D Wright, Feng Gao, et al.
American Journal of Obstetrics and Gynecology
|
August 5, 2022
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer
Michelle D S Lightfoot, Ashley S Felix, Corinne A Calo, et al.
Page
of 31